Thomas John Dietz - Insider Trading & Ownership

Location
C/O Transcept Pharmaceutical, Inc., 1003 W. Cutting Blvd, Ste 110, Pt. Richmond, CA
Summary
The estimated net worth of Thomas John Dietz is at least $21.1K dollars as of November 13, 2025. Thomas John Dietz is the Director of Eiger BioPharmaceuticals, Inc. and owns shares of Eiger BioPharmaceuticals, Inc. stock worth about $21.1K.
Signature
/s/ Douglas E. Onsi as attorney-in-fact for the reporting person
All Insider Reports
All Insider Reports

Ownership of Thomas John Dietz

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
EIGR Eiger BioPharmaceuticals, Inc. Director $21.1K Mar 1, 2023
LPTX LEAP THERAPEUTICS, INC. Director Nov 11, 2025
PRTK Paratek Pharmaceuticals, Inc. Director Sep 21, 2023

Insider Transactions Reported by Thomas John Dietz:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.